Clinical trial Recruiting at 3 sites Observational

Long-term health effects in childhood cancer survivors

Official title: The Swiss Childhood Cancer Survivor Study - Follow-up (SCCSS-FollowUp)

Run by University of Bern · NCT04732273 · Data updated 2026-11-12

This study looks at the long-term health effects that childhood cancer survivors in Switzerland may face as they grow up to help improve their care and quality of life.

More Childhood Cancer trials

Quick facts

Study typeObservational
SexAll
Enrollment3000 (estimated)
SponsorUniversity of Bern
Academic / other
Locations3 sites (Basel and 2 other locations)
StatusRecruiting
StartedJune 20, 2022
Main results expectedJanuary 1, 2071
Study endsJanuary 1, 2071
Registry record updatedSeptember 23, 2025
Trial IDNCT04732273 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are individuals who were diagnosed with cancer at age 0-20 years, have completed their treatment, and are currently residing in Switzerland.

Probably not a fit

Patients who are in a palliative or relapsed situation where no follow-up examinations are planned will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The SCCSS-FollowUp is a national, multicenter cohort study aimed at investigating the late effects experienced by childhood cancer survivors in Switzerland. This observational study collects data through clinical examinations, laboratory tests, functional assessments, and questionnaires to understand the prevalence and risk factors associated with these late effects. By standardizing follow-up care and assessing survivors longitudinally, the study seeks to minimize chronic diseases and improve the quality of life for this population. The findings will help inform healthcare strategies for managing the long-term health of childhood cancer survivors.

Why it matters

Potential benefit: If successful, this study could lead to improved monitoring and management of late effects in childhood cancer survivors, enhancing their quality of life.

How similar studies have gone: Other studies have successfully investigated late effects in childhood cancer survivors, indicating that this approach is both relevant and necessary.

Who can join: the full rules

Show full inclusion / exclusion criteria
This prospective cohort study is based on the Childhood Cancer Registry (ChCR), a national, population-based cancer registry that includes all children and adolescents in Switzerland who were diagnosed with cancer at age 0-20 years. It includes patients diagnosed with leukemia, lymphoma, central nervous system tumors, and malignant solid tumors or Langerhans cell histiocytosis.

Inclusion Criteria:

* Registered in the Childhood Cancer Registry (ChCR) or treated and followed-up in a Swiss pediatric oncology (SPOG) clinic, but not registered in the ChCR because of residency in neighboring countries
* Diagnosed at age 0 - 20 years
* Childhood cancer treatment completed
* All age categories at time of inclusion in the study (children, adolescents, adults)
* Written informed consent

Exclusion criteria:

* Childhood cancer survivors in a palliative or relapsed situation where no follow-up examinations are foreseen.

Where it's running

  • University Childen's Hospital Basel
    Basel, Switzerland
    Recruiting
  • University Children's Hospital Bern
    Bern, Switzerland
    Recruiting
  • University Hospital Geneva
    Geneva, Switzerland
    Recruiting

Study contacts

  • Principal investigator: Claudia E Kuehni, MD — Institute of Social and Preventive Medicine, University of Bern
  • Study coordinator: Claudia E Kuehni, MD
  • Email: claudia.kuehni@unibe.ch
  • Phone: +41 31 631 35 07

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.